New Two-Drug attack on tough breast cancers
Disease control
Recruiting now
This study is testing a new combination of two drugs for people with advanced breast cancer that has spread and is hard to treat. The main goals are to see if the combination is safe and if it can shrink or control the cancer. It will enroll about 50 people with specific types of…
Phase: PHASE1, PHASE2 • Sponsor: Marengo Therapeutics, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC